Eisenstadt Richard I 4
4 · Altimmune, Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
Eisenstadt Richard I
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.0001
2023-12-29$11.25/sh−3,044$34,245→ 33,291 total - Exercise/Conversion
Common Stock, par value $0.0001
2023-12-29+12,500→ 36,335 total - Exercise/Conversion
Restricted Stock Units
2023-12-29−12,500→ 25,000 total→ Common Stock, par value $0.0001 (12,500 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]The RSUs become vested and exercisable over four (4) years with 25% of the shares vesting on December 31, 2022, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.